Covered recipient · General Payments record
COLIN MICHAEL RIDENOUR
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2019–2025
$1,872.46
- Reported across 61 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $383.45 | 16 |
| Honoraria | $32.44 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Vision LLC | $167.95 | 6 |
| ABBVIE INC. | $115.33 | 6 |
| GLAUKOS CORPORATION | $57.38 | 2 |
| RxSight Inc | $32.44 | 1 |
| Astellas Pharma US Inc | $22.11 | 1 |
| Ocular Therapeutix, Inc. | $20.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.48 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203856687 | CMS |
| ABBVIE INC. | $14.72 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203856693 | CMS |
| ABBVIE INC. | $14.23 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203856697 | CMS |
| ABBVIE INC. | $22.62 | 07/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203856704 | CMS |
| ABBVIE INC. | $21.43 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203856709 | CMS |
| ABBVIE INC. | $23.85 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203856714 | CMS |
| Alcon Vision LLC | $14.72 | 01/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207484257 | CMS |
| Alcon Vision LLC | $67.58 | 04/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207484285 | CMS |
| Alcon Vision LLC | $21.65 | 07/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207484321 | CMS |
| Alcon Vision LLC | $29.01 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207484349 | CMS |
| Alcon Vision LLC | $15.89 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207484371 | CMS |
| Alcon Vision LLC | $19.10 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207484409 | CMS |
| Astellas Pharma US Inc | $22.11 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238627599 | CMS |
| Glaukos Corporation | $27.63 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246408540 | CMS |
| Glaukos Corporation | $29.75 | 08/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246408636 | CMS |
| Ocular Therapeutix, Inc. | $20.68 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250227169 | CMS |
| RxSight Inc | $32.44 | 02/04/2025 | Honoraria | Undisputed | 06/30/2026 | 1251711245 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.